Jason Ross

Cancer diagnostic researcher, epigeneticist, bioinformatician. Keen cyclist, coffee addict and live music fan.

[Jason Ross @JasonR055]

Our new mini-review on epigenetic diagnostics for minimal residual disease. It turns out there's a fair bit around the corner.
https://t.co/GlXKsMsrD6

[Jason Ross @JasonR055]

We're looking for a talented biostatistician with experience in molecular diagnostics to join our team at CSIRO Westmead. https://t.co/cjk8QqV2e9

[Andrew Johnston @ADJohnston85]

Introducing the latest in Illumina automation technology. The first genetically modified laboratory assistant. 10,000x smarter than the average rat and capable of performing all Illumina NGS workflows out of the cage. #AusEpi22 #GMO
#Genomics4All no matter how small.

[Australasian Epigenetics Alliance @AEpiA]

Epigenetics 2022!

Bringing together fantastic Epigenetics research in beautiful northern NSW

Enjoy the conference dinner tonight
🥂🎉💃🕺

@AEpiA #AusEpi22

[Belinda Phipson @BelindaPhipson]

I'm looking for a postdoc to join my lab with a focus on developing methods for single cell & spatial data, coupled with exciting collaborative projects in this space. My goal is to foster a supportive & collaborative environment. Apply here -> https://t.co/phQWinY0YH

[Australasian Epigenetics Alliance @AEpiA]

Earlybird and oral abstract deadline is only 1 week away!

Submit your abstract now to share your research with other like minded scientists! https://t.co/ZFzovs3AVX

We look forward to seeing you there! #AusEpi22

[Australasian Epigenetics Alliance @AEpiA]

EARLYBIRD AND ORAL ABSTRACT
SUBMISSION CLOSING SOON!!

Less than 1 month until earlybird registration and oral abstract submissions close. Register now and don't delay!

Closing Friday 3rd June.
Visit: https://t.co/1qZiCfY2Dz

We can't wait to see you there!

[Jason Ross @JasonR055]

Are you undertaking an EWAS methylation study? Our new paper demonstrates why you should care about batch effects, and what probes are troublesome. There's handy probe filtering lists to download as well. https://t.co/qBdgIUEdJ6

[Australasian Epigenetics Alliance @AEpiA]

You are invited to Epigenetics 2022! #AusEpi22

11-14 September 2022, Kingscliff NSW

Themes:

1⃣ Epigenetics & disease
2⃣ Reprogramming & transgenerational epigenetics
3⃣ Emerging techniques
4⃣ Epigenetic regulation/mechanisms.

#Epigenome #DNAregulation

https://t.co/0Fvdd2vj1m

[Australasian Epigenetics Alliance @AEpiA]

Announcing the conference themes for #AusEpi22 1) Epigenetics & disease, 2) Reprogramming & transgenerational epigenetics, 3) Emerging techniques & 4) Epigenetic regulation/mechanisms. Find out more, including the draft program, on the conference website https://t.co/ZFzovskDXX

[Jason Ross @JasonR055]

@Chachans78 @bella_tuscany @PlasFron @MichaelMac1798 Clearly you have no knowledge of viral epidemiology

[Jason Ross @JasonR055]

@HamillHimself Sold out to big pharma, big government, big bird! 😉

[Australasian Epigenetics Alliance @AEpiA]

Save the date! AEpiA Epigenetics Conference is back, 11-14 Sept 2022, for a face to face meeting in Kingscliff NSW. Registration and abstracts will open early 2022 #AusEpi22

[Jason Ross @JasonR055]

@ElZorres9 @TnAlistair @Asset90210 @DrKate_Miller Hi there, the modified mRNA doesn't suppress a toll-like receptor response, it just evades creating one so the mRNA has a chance to be translated into protein.

[Jason Ross @JasonR055]

@elizabethaself Good on you, Elizabeth. It's a courageous act to critically weigh things up and decide that moving on is the best strategy. Best wishes on your new adventures in the unknown.

[Jason Ross @JasonR055]

@fabian_theis Nothing significant? Machine learning to the rescue 😏

[Jason Ross @JasonR055]

@mikelove Bioconductor GenomicRanges lib for the win!

[Jason Ross @JasonR055]

@TnAlistair @DrKate_Miller @Asset90210 Thank you also.

[Jason Ross @JasonR055]

@TnAlistair @DrKate_Miller @Asset90210 Afraid or uncomfortable? Nope.

The point seemed a little redundant and disingenuous re: the safety profile of mRNA vaccines.

The World was not in a position to wait into May 2023 until that trial concluded on paper. Not a normal trial either, but an umbrella for phase 1-3.

[Jason Ross @JasonR055]

@TnAlistair @DrKate_Miller @Asset90210 In time, there will be all the post-approval surveillance data to address your concerns too re: long term effects.